PCBMI
Home
PCBMI¼Ò°³
¿¬±¸¿ø¼Ò°³
¼³¸³¸ñÀû
¼³¸³°æ°ú
Á¶Á÷µµ
À§Ä¡¾È³»
¿¬±¸È°µ¿
ÁßÁ¡¿¬±¸ºÐ¾ß
°øµ¿¿¬±¸»ç¾÷ ÇöȲ
¿¬±¸È¸
»ç¾÷ ½Åû
°Ô½ÃÆÇ
°øÁö»çÇ×
»õ¼Ò½Ä
°úÁ¦°ø¸ðÇöȲ
À¥Áø POCAPIA
ÇàÁ¤Áö¿ø
¾÷¹«¾È³»
½Ã¼³ÀÌ¿ë
°¢Á¾¼½Ä
Total 131
¹øÈ£
Á¦ ¸ñ
±Û¾´ÀÌ
³¯Â¥
Á¶È¸
°øÁö
Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø °³ÀÎÁ¤º¸Ã³¸®¹æÄ§ Á¦Á¤ °øÁö
ÃÖ°í°ü¸®ÀÚ
2021-03-25
339
°øÁö
[°ø°í] 2021³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/26(±Ý)>
ÃÖ°í°ü¸®ÀÚ
2021-02-08
681
131
Æ÷½ºÅØ-°¡Å縯´ë ÀÇ»ý¸í°øÇבּ¸¿ø °³ÀÎÁ¤º¸Ã³¸®¹æÄ§ Á¦Á¤ °øÁö
ÃÖ°í°ü¸®ÀÚ
2021-03-25
339
130
[°ø°í] 2021³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/26(±Ý)>
ÃÖ°í°ü¸®ÀÚ
2021-02-08
681
129
[°ø°í] 2020³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í<~2/21(±Ý)>
ÃÖ°í°ü¸®ÀÚ
2020-02-03
3130
128
PoCa Research Village Night °³ÃÖ ¾È³»
ÃÖ°í°ü¸®ÀÚ
2020-01-10
3182
127
[Æ÷-°¡ °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª] Peptides from Hemostatic Effects to Gene Delivery_Ȳº´Èñ ±³¼ö(ÀÎõ´ë,¡¦
ÃÖ°í°ü¸®ÀÚ
2019-12-24
2988
126
[Æ÷-°¡ ¿¬±¸¿ø ÃÊû¼¼¹Ì³ª] Àú°µµ ÁýÁßÃÊÀ½ÆÄ¸¦ ÀÌ¿ëÇÑ ºñħ½ÀÀû ³ú±â´É Á¶Àý ¿¬±¸(¹Ú»óÀÎ ¹Ú»ç, ÀÎõ¼º¸ð¡¦
ÃÖ°í°ü¸®ÀÚ
2019-11-05
2991
125
[Æ÷-°¡ ¿¬±¸¿ø °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª] Overview of cancer immunotherapy_µµÁØ»ó ±³¼ö(¼¿ï´ë)_07/23(È)¡¦
ÃÖ°í°ü¸®ÀÚ
2019-07-15
3207
124
¼¿ï¼º¸ðº´¿ø ¾Ïº´¿ø-Æ÷½ºÅØ °øµ¿ ½ÉÆ÷Áö¿ò °³ÃÖ ¾È³»
ÃÖ°í°ü¸®ÀÚ
2019-06-25
3158
123
[Æ÷-°¡ ¿¬±¸¿ø °øµ¿¿¬±¸ÆÀ ÃÊû¼¼¹Ì³ª] ½ÅÀÇ·á±â¼úÆò°¡ Á¦µµÀÇ ÀÌÇØ_5/21(È) 17½Ã, Çѱ¹º¸°ÇÀǷῬ±¸¿ø ±è¡¦
ÃÖ°í°ü¸®ÀÚ
2019-05-21
2700
122
2019³â Æ÷½ºÅØ-°¡Å縯´ë °øµ¿¿¬±¸Áö¿ø»ç¾÷(¿¬±¸È¸) °ø°í[~2/22(±Ý)]
ÃÖ°í°ü¸®ÀÚ
2019-02-11
1376
121
[Æ÷-°¡ ¿¬±¸¿ø ÃÊû ¼¼¹Ì³ª] TRANSPORT PHENOMENA UNDER NANOSCALE CONFINEMENT, Æ÷½ºÅØ ±â°è°øÇаú ¹ÚÇü±Ô¡¦
ÃÖ°í°ü¸®ÀÚ
2019-01-21
3167
120
PoCa Research Village Night °³ÃÖ ¾È³»
ÃÖ°í°ü¸®ÀÚ
2019-01-18
3070
119
¼¿ï¼º¸ðº´¿ø ¾Ïº´¿ø-Æ÷½ºÅØ °øµ¿ ½ÉÆ÷Áö¿ò °³ÃÖ ¾È³»(2018.11.23, Æ÷½ºÅØ Ã¶°´ëÇпø ´ë°´ç)
ÃÖ°í°ü¸®ÀÚ
2018-10-29
3246
118
[Æ÷-°¡ ¿¬±¸¿ø ÃÊû ¼¼¹Ì³ª] Æ÷½ºÅØ ÀÌÀ¯Á¤ & ÀÌÁ¤¿í ±³¼ö ÃÊû ¼¼¹Ì³ª
ÃÖ°í°ü¸®ÀÚ
2018-08-20
4042
117
Æ÷-°¡ °øµ¿¿¬±¸ÆÀ ÃÊû ¼¼¹Ì³ª_Power to the patient?_Dr.Gantner(MD, Ph.D, MBA, LL.M.)
ÃÖ°í°ü¸®ÀÚ
2018-06-19
3838
1
2
3
4
5
6
7
8
9
Á¦¸ñ
³»¿ë
Á¦¸ñ+³»¿ë
ȸ¿ø¾ÆÀ̵ð
ȸ¿ø¾ÆÀ̵ð(ÄÚ)
±Û¾´ÀÌ
±Û¾´ÀÌ(ÄÚ)
and
or
Á¦¸ñ ¾øÀ½